Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D003510:Cyclohexanes; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*
D003510:Cyclohexanes; D009607:Nitrosourea Compounds; D014747:Vinblastine